John Trizzino, EVP, Chief Commercial Officer at NOVAVAX INC (NVAX), sold 3,718 shares at $170.25 ($613K) on 2021-03-05, disclosed to the SEC on 2021-03-09.
Open-market sale of $613k NVAX by EVP, Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $150.31 | 72 | $11K | 1.8% |
| 2 | $152.39 | 150 | $23K | 3.7% |
| 3 | $153.24 | 312 | $48K | 7.8% |
| 4 | $154.00 | 185 | $28K | 4.6% |
| 5 | $155.64 | 135 | $21K | 3.4% |
| 6 | $157.08 | 160 |
| $25K |
| 4.1% |
| 7 | $159.02 | 101 | $16K | 2.6% |
| 8 | $160.82 | 172 | $28K | 4.5% |
| 9 | $163.53 | 162 | $26K | 4.3% |
| 10 | $166.48 | 263 | $44K | 7.1% |
| 11 | $167.73 | 167 | $28K | 4.6% |
| 12 | $168.89 | 91 | $15K | 2.5% |
| 13 | $170.25 | 336 | $57K | 9.3% |
| 14 | $171.23 | 314 | $54K | 8.8% |
| 15 | $171.23 | 314 | $54K | 8.8% |
| 16 | $172.24 | 203 | $35K | 5.7% |
| 17 | $173.54 | 186 | $32K | 5.3% |
| 18 | $174.84 | 179 | $31K | 5.1% |
| 19 | $174.84 | 14 | $2K | 0.4% |
| 20 | $175.16 | 12 | $2K | 0.3% |
| 21 | $168.09 | 190 | $32K | 5.2% |
| Total | $164.95 avg | 3,718 | $613K | 100% |
| Filing → |
| NVAX | SELL | 2021-09-22 | $6.8M | — | Filing → |
| NVAX | SELL | 2021-09-15 | $7.0M | — | Filing → |
| NVAX | SELL | 2021-05-07 | $802K | — | Filing → |